July 11, 2023 5:04 AM ET By Will Stone Scientists have shown that the antibiotic doxycycline can ward off illnesses like chlamydia, gonorrhea and syphilis. It’s a prevention tool called doxy-PEP. MirageC/Getty Images A promising line of attack against sexually transmitted infections puts a cheap and widely available medication to a new use. The treatment –...
Tag: <span>old drug</span>
Teaching an old drug new tricks
by Texas Tech University Sanjay Srivastava, Ph.D., recently received a U.S. patent for repurposing pimavanserin to treat various types of cancer. Credit: TTUHSC To treat some of the psychosis issues associated with Parkinson’s disease, physicians often prescribe pimavanserin, an antipsychotic drug that acts within the brain to prevent hallucinations and delusions. Because of its ability...
Old drug may have new trick: protecting against COVID-19 lung injury
WEILL CORNELL MEDICINE An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury and the risk of blood clots in severe COVID-19 and other disorders that cause immune-mediated damage to the lungs, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring...
Another old drug is being tried against COVID-19, and might actually help
by Tom Avril Credit: CC0 Public Domain In the first few weeks of the pandemic, when physicians were grappling with the unknown like everyone else, psychiatrist Angela Reiersen recalled that an old drug in her field, called fluvoxamine, affected the body in ways that went beyond improving mental health. In addition to easing symptoms of...
Breast cancer researchers learn how to teach an old drug new tricks to help patients
by Chris Malina, University of Wisconsin-Madison Beth Weaver wanted to know if there was a way to predict who would benefit from Taxol and who might not, to spare these patients the side effects of the potent chemotherapy drug. Credit: UW Carbone Cancer Center Paclitaxel, or Taxol, is an old standby drug in the oncologist’s tool...
New use of old drug reduces risk of kidney cancer returning
by European Association of Urology Credit: CC0 Public Domain Using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of cancer recurring by a third, according to new research. The findings from the Phase III trial are presented today at the European Association of Urology Congress (EAU21). There...